Stix expands from at-home pregnancy and ovulation tests to UTI products with $3.5M seed
22 Apr, 2021
– Cleo, the leading family benefits platform supporting working families in the planning stage through the teenage years, today announced a $40m Series C investment led by Transformation Capital, with participation from Glynn Capital, PruVen Capital and Gaingels and existing investors Greylock, NEA and Felicis.
– In conjunction with this round, Transformation Capital Managing Partner, Mike Dixon will join Cleo’s Board. This round brings Cleo’s total funding to $83m.
– Since its founding in 2016, Cleo has become the industry’s most complete and high-impact family benefits platform. Its products and services help a diverse set of more than 100 leading employers attract, retain, and drive better health outcomes for working parents in over 55 countries.